Literature DB >> 9029152

Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein.

M G Frattini1, S D Hurst, H B Lim, S Swaminathan, L A Laimins.   

Abstract

Human papillomavirus (HPV) E2 and E1 proteins are required for the replication of viral genomes in vivo. We have examined the effects of increasing the level of E2 on viral and cellular replication using recombinant adenoviruses. Infection of cells which maintain HPV 31 DNA episomally with E2 recombinant adenoviruses resulted in a 5-fold increase in genome copy number as well as an S phase arrest allowing for the continued replication of cellular DNA. Similar effects on cell cycle progression were seen following infection of normal human foreskin keratinocytes, the natural host cell. The DNA content of these cells increased beyond 4N indicating that multiple rounds of replication had occurred without an intervening mitotic event. In addition, increased cyclin A and E associated kinase activity was observed, while no change was detected in cyclin B associated kinase activity or in the activation state of cdc2 kinase. Interestingly, the levels of the p53 tumor suppresser protein were dramatically reduced through a post-transcriptional mechanism following infection. These data suggest a role for E2 in regulating viral and cellular replication by abrogation of a mitotic checkpoint, which is, at least in part, controlled by p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029152      PMCID: PMC1169638          DOI: 10.1093/emboj/16.2.318

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  Mechanisms restricting DNA replication to once per cell cycle: MCMS, pre-replicative complexes and kinases.

Authors:  P Romanowski; M A Madine
Journal:  Trends Cell Biol       Date:  1996-05       Impact factor: 20.808

Review 3.  Qualifying for the license to replicate.

Authors:  T T Su; P J Follette; P H O'Farrell
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

4.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.

Authors:  H Romanczuk; F Thierry; P M Howley
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.

Authors:  M C McIntyre; M G Frattini; S R Grossman; L A Laimins
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 6.  The biology of human papillomaviruses: from warts to cancer.

Authors:  L A Laimins
Journal:  Infect Agents Dis       Date:  1993-04

7.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.

Authors:  S Swaminathan; B Thimmapaya
Journal:  J Mol Biol       Date:  1996-05-24       Impact factor: 5.469

9.  Linkage of replication to start by the Cdk inhibitor Sic1.

Authors:  B L Schneider; Q H Yang; A B Futcher
Journal:  Science       Date:  1996-04-26       Impact factor: 47.728

10.  The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.

Authors:  F Thierry; M Yaniv
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  35 in total

1.  The Antiproliferative Effect of the "Early" Protein E2 of Papillomavirus HPV16 on Testis Tumors of Mice Induced by the Injection of HeLa Cells.

Authors:  R K Salyaev; N I Rekoslavskaya; A S Stolbikov
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

2.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  p53 and hTERT determine sensitivity to viral apoptosis.

Authors:  Marie L Nguyen; Rachel M Kraft; Martine Aubert; Edward Goodwin; Daniel DiMaio; John A Blaho
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

5.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line.

Authors:  Samina Alam; Ellora Sen; Heidi Brashear; Craig Meyers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Authors:  Liisi Võsa; Aleksander Sudakov; Maido Remm; Mart Ustav; Reet Kurg
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

8.  A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.

Authors:  Margaret Rush; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.

Authors:  Kimberly Johung; Edward C Goodwin; Daniel DiMaio
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

10.  Human papillomaviruses: a growing field.

Authors:  Denise A Galloway
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.